Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Eur Respir J. 2021 Aug 26;58(2):2101483.
doi: 10.1183/13993003.01483-2021.
Print 2021 Aug.
1 Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
2 German Centre of Lung Research (DZL), Germany.
3 Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
4 GWT-TUD GmbH, Epidemiological Centre, Dresden, Germany.
5 Centre for Pulmonary Hypertension, Thoraxclinic Heidelberg GmbH at Heidelberg University Hospital, Heidelberg, Germany.
6 Institute of Biometry and Clinical Epidemiology, Charité Universitätsmedizin, Berlin, Germany.
7 Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
8 Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), and the Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
9 Dept of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.